Spectrum Pharmaceuticals Long Term Debt

Spectrum Pharmaceuticals (SPPI) currently reports a long-term debt of $29M as of March 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Spectrum Pharmaceuticals's long-term debt history and peer comparisons.

Spectrum Pharmaceuticals's long-term debt changed from $0 to $29M (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spectrum Pharmaceuticals reported $29M in long-term debt as of March 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Spectrum Pharmaceuticals, and consider following SPPI for alerts when major investors trade the stock.

Spectrum Pharmaceuticals is classified in the Healthcare sector. On long-term debt, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPPI with unrelated industries.